Melanoma Management

Aims & Scope

Skin cancer is on the rise.

According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year.

While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably.

Therefore, research into combating advanced-stage melanoma is a high priority.

New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing.

Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis.

The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field.

Independent drug evaluations assess newly approved medications and their role in clinical practice.

Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,415.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Skin Cancer Screening: Recommendations for Data-Driven Screening Guidelines and a review of the US Preventive Services Task Force Controversy

  Citation: 108

  Authors: Mariah M, Sancy A, Lisa G, Lee D, Clara, Vernon K, Clara E, Susan M, John, Tawnya, Robert P, Larisa J, Douglas, Kenneth F, Jason E, Joanne M, Caroline C, John M, Aaron R, Frank, Michael E, Kelly C, Michael, Brian P, June K, Arthur J, Shannon, Suraj S, Sanjiv, Rhoda, Bruce, Anna, Mirna, Neil, William, Pamela B, Suephy C, Emily Y, Darrel L, Laura K, David E, Kari, David H, Philip D, Kim A, Svetomir, Mary C, Debbie, Debjani, William H, Jennifer, Alexander J, Ahmad, Matthew H, Oliver J, Michael K

• Combatting Mucosal Melanoma: Recent Advances and Future Perspectives

  Citation: 90

  Authors: Helen, Miranda

• Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia

  Citation: 83

  Authors: Michelle R, Adèle C

• Advances in the use of Reflectance Confocal Microscopy in Melanoma

  Citation: 48

  Authors: Andréanne, Phoebe, Pascale

• The Role for Chemotherapy in the Modern Management of Melanoma

  Citation: 36

  Authors: Avinash, Fabio, Paul

• Epidemiology and Survival Outcomes in Stages II and III Cutaneous Melanoma: A Systematic Review

  Citation: 35

  Authors: Rachael, Sophie, Irene, Agnes, Kevin, Emilie

• Is the Neutrophil-to-Lymphocyte Ratio a Useful Prognostic Indicator in Melanoma Patients?

  Citation: 34

  Authors: Joshua T, Thomas J, Michael P

• Surveillance Imaging for Metastasis in High-Risk Melanoma: Importance in Individualized Patient Care and Survivorship

  Citation: 34

  Authors: Morganna, Shachar

• Biology and Treatment of BRAF Mutant Metastatic Melanoma

  Citation: 33

  Authors: Benjamin Y, Matteo S, Alexander M

• Prognostic Gene Expression Profiling in Melanoma: Necessary Steps to Incorporate into Clinical Practice

  Citation: 33

  Authors: Douglas, Caroline C, Rebecca I, Elizabeth, Kelly C, Nwanneka, Clara, Sancy A, Susan M